Bionomics Limited

ASX (AUD): Bionomics Limited (BNO)

Last Price

0.01

Today's Change

0.00 (0.00%)

Day's Change

0.009 - 0.011

Trading Volume

5,691,545

Overview

Market Cap

13 Million

Shares Outstanding

1 Billion

Avg Volume

2,864,558

Avg Price (50 Days)

0.02

Avg Price (200 Days)

0.03

PE Ratio

-0.45

EPS

-0.02

Earnings Announcement

31-Aug-2023

Previous Close

0.01

Open

0.01

Day's Range

0.009 - 0.011

Year Range

0.009 - 0.074

Trading Volume

4,414,396

Price Change Highlight

1 Day Change

0.00%

5 Day Change

0.00%

1 Month Change

-10.00%

3 Month Change

-50.00%

6 Month Change

-60.87%

Ytd Change

-74.29%

1 Year Change

-99.97%

3 Year Change

-94.09%

5 Year Change

-98.27%

10 Year Change

-98.75%

Max Change

-98.63%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment